ZaiLab takes a monumental leap in the world of biotechnology equality скачать в хорошем качестве

ZaiLab takes a monumental leap in the world of biotechnology equality

Founded in 2014 to address the significant unmet medical needs in China, Zai Lab is a patient-oriented biotechnology research company, dedicated to the development and delivery of first class medicines for “oncology, autoimmune disorders, infectious diseases and neurological disorders to patients in greater China and around the world.” In recent years China has become one of the most dynamic R&D hubs for innovative medicines across the world. Zai Lab has partnered with leading global biopharmaceutical companies, generating a broad pipeline of innovative late-stage drug candidates, four of which have now been launched in China. The company has quickly become a partner of choice for global companies seeking access to the Chinese market. Zai Lab’s longer-term goal is to become a leading global biopharmaceutical company, leveraging its China-based competencies and resources to provide healthcare products to patients around the world. The company is now a fully integrated biopharmaceutical company with four marketed products in China and a growing pipeline with several programs that have global rights. _________________________________________________________________________________________________ TBD Media is an international purpose driven media group that helps companies, organisations and governments tell their brand stories in a direct and human way. Combining over 30 years of experience in marketing, content creation, video production and publishing, our senior team have been providing thought-provoking content since 2015. Learn more about our projects and campaigns on: https://www.tbdmediagroup.com/ Follow us on social media! Facebook: @TBDMedia Twitter: @TBD_Media LinkedIn: TBD Media Group Instagram: @tbdmediagroup